We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Citrate anticoagulation using ACD solution A during long-term haemodialysis.
- Authors
Wright, Stephen; Steinwandel, Uli; Ferrari, Paolo
- Abstract
Haemodialysis with regional citrate anticoagulation in patients with contraindications for heparin is increasingly performed in the USA and Europe. Most published protocols use trisodium citrate, which is not readily available nor is it licensed in Australia. We established a protocol for citrate-anticoagulation in haemodialysis using acid citrate dextrose solution A (ACDA), which is approved for apheresis procedures in Australia. The aim of the present study was to assess the safety and efficacy of this protocol for routine use in haemodialysis patients. Systemic and post-filter blood ionized calcium, serum sodium and bicarbonate and dialyzer clotting score were analyzed prospectively in 14 patients undergoing 150 consecutive haemodialysis treatments with citrate anticoagulation using calcium-free dialysate. A simple algorithm allowed the attending nurse to adjust citrate infusion (to maintain post-filter ionized calcium at 0.2-0.3 mmol/L) and i.v. calcium substitution. Scheduled dialysis time was 4 h, and point-of-care monitoring of blood ionized calcium during dialysis was done at 0, 15, 60, 120 and 240 min. ACDA infusion rates of 300 mL/h were used in the first 52 treatments, but resulted in high dialyzer clotting score and 6% of treatments were discontinued due to complete clotting. Thereafter, ACDA infusion rate was increased to 350 mL/h, with all 98 subsequent treatments completed successfully. Ionized calcium levels were stable during all procedures with post-dialysis serum sodium averaging 135 ± 3 mmol/L and bicarbonate 23.8 ± 2 mmol/L. Routine use of citrate anticoagulation in the setting of a long-term haemodialysis unit is safe and efficient. Point-of-care measurements of ionized calcium levels are critical to safely and successfully perform citrate anticoagulation. This study documents that the use of citrate anticoagulation with acid citrate dextrose solution A (ACDA) is a safe and efficient alternative in haemodialysis patients when conventional or fractioned heparin is contraindicated. To maintain a post-filter ionized calcium of 0.2-0.3 mmol/L the ACDA infusion rate should be 350 mL/h, as there is an increased risk of clotting at 300 mL/h. It is important that the ionized calcium is monitored and replaced with i.v. calcium to prevent systemic hypocalcaemia.
- Subjects
UNITED States; EUROPE; HEMODIALYSIS patients; CITRATES; DEXTROSE; HEPARIN; HEMODIALYZERS; INFUSION therapy
- Publication
Nephrology, 2011, Vol 16, Issue 4, p396
- ISSN
1320-5358
- Publication type
Article
- DOI
10.1111/j.1440-1797.2010.01421.x